![Faheem Hasnain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Faheem Hasnain
Chief Executive Officer at
GOSSAMER BIO, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Faheem Hasnain is a businessperson who founded Gossamer Bio, Inc. and who has been the head of 11 different companies. Mr. Hasnain holds the position of Chairman of Mirati Therapeutics, Inc., Chairman of SENTÉ, Inc. (California), Chairman, President & Chief Executive Officer for Gossamer Bio, Inc. and Chairman at Aspen Neuroscience, Inc. Mr. Hasnain is also on the board of Kura Oncology, Inc. and Member-Overseers Board at The Scripps Research Institute. In the past Faheem Hasnain held the position of President, Chief Executive Officer & Director at PDL BioPharma, Inc., President-Oncology Therapeutics Network at Bristol Myers Squibb Co. and President, Chief Executive Officer & Director at Receptos LLC (a subsidiary of Bristol Myers Squibb Co.), Executive Vice President at Biogen, Inc. and EVP-Oncology & Rheumatology Strategic Business at Biogen Idec, Inc. (North Carolina) (a subsidiary of Biogen, Inc.), Vice President-Global eBusiness at GlaxoSmithKline Plc, Chairman for Ambit Biosciences Corp., Chairman at Tocagen, Inc., Chairman at Vital Therapies, Inc., President, Chief Executive Officer & Director at Abbott Biotherapeutics Corp. and President for Oncology Therapeutics Network Corp. Mr. Hasnain received an undergraduate degree from the University of Windsor.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GOSSAMER BIO, INC. 1.13% | 2026-04-19 | 5,528,366 ( 1.13% ) | 1 M $ | 2026-05-30 |
KURA ONCOLOGY, INC. 0.03% | 2026-06-03 | 23,983 ( 0.03% ) | 244 627 $ | 2026-05-30 |
Faheem Hasnain active positions
| Companies | Position | Start |
|---|---|---|
| KURA ONCOLOGY, INC. | Director/Board Member | 2015-04-26 |
| GOSSAMER BIO, INC. | Chief Executive Officer | 2020-11-15 |
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Chairman | 2021-03-31 |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, medical and technology sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 2019-12-31 |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services | Chairman | 2020-04-05 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2017-12-31 |
SENTÉ Labs | Chairman | 2007-12-31 |
Former positions of Faheem Hasnain
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Chairman | 2024-01-22 |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Chairman | 2021-01-31 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Faheem Hasnain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
27
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 27 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Oncology Therapeutics Network Corp.
 Oncology Therapeutics Network Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals to oncologists | Distribution Services |
University of Windsor
 University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
SENTÉ, Inc. (California)
 SENTÉ, Inc. (California) Specialty StoresRetail Trade Retails skin care products through online | Retail Trade |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Pernix Sleep, Inc.
 Pernix Sleep, Inc. Medical/Nursing ServicesHealth Services Provides insomnia treatment services | Health Services |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, medical and technology sectors. It provides financing for early stage capital requirements. | Finance |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services | Health Services |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SENTÉ Labs | |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Health Technology |
- Stock Market
- Insiders
- Faheem Hasnain
